Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
Visa övriga samt affilieringar
2020 (Engelska)Ingår i: Orphanet Journal of Rare Diseases, E-ISSN 1750-1172, Vol. 15, nr 1, artikel-id 179Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Patisiran, an RNA interference therapeutic, has demonstrated robust reduction of wild-type and mutant transthyretin protein and was able to improve polyneuropathy and quality of life following 18 months of treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.In this 24-month Phase II open-label extension study, we evaluated the effects of patisiran treatment (0.3 mg/kg intravenously every 3 weeks) on safety, serum transthyretin levels, and clinical parameters. Efficacy assessments included modified Neuropathy Impairment Score +7 (mNIS+7) and multiple disease-relevant measures. Cardiac assessments were performed in a pre-specified cardiac subgroup.

Results: Twenty-seven patients entered this study, including 12 (44%) with ambulation difficulties due to their neuropathy and 11 (41%) who met criteria for the cardiac subgroup. During treatment, the majority of adverse events were mild/moderate in severity; there were no drug-related adverse events leading to treatment discontinuation. The most common drug-related adverse events were flushing and infusion-related reactions (22% each). Patisiran resulted in rapid, robust (similar to 82%), and sustained reduction of mean transthyretin levels over 24 months. A mean 6.95-point decrease (improvement) in mNIS+7 from baseline was observed at 24 months. Patisiran's impact on mNIS+7 was irrespective of concomitant tafamidis or diflunisal use, sex, or age. Clinical assessments of motor function, autonomic symptoms, disease stage, and quality of life remained stable over 24 months. No significant changes were observed for echocardiographic measures or cardiac biomarkers in the cardiac subgroup. Exploratory analyses demonstrated improvements in nerve-fiber density with corresponding reductions in amyloid burden observed in skin biopsies over 24 months.

Conclusions: Long-term treatment with patisiran had an acceptable safety profile and was associated with halting/improvement of polyneuropathy progression in patients with hATTR amyloidosis.

Ort, förlag, år, upplaga, sidor
BioMed Central (BMC), 2020. Vol. 15, nr 1, artikel-id 179
Nyckelord [en]
ATTR amyloidosis, Cardiomyopathy, Patisiran, Polyneuropathy, RNA interference
Nationell ämneskategori
Neurologi
Identifikatorer
URN: urn:nbn:se:umu:diva-174053DOI: 10.1186/s13023-020-01399-4ISI: 000551966000001PubMedID: 32641071Scopus ID: 2-s2.0-85087693350OAI: oai:DiVA.org:umu-174053DiVA, id: diva2:1457842
Tillgänglig från: 2020-08-13 Skapad: 2020-08-13 Senast uppdaterad: 2024-03-14Bibliografiskt granskad

Open Access i DiVA

fulltext(951 kB)155 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 951 kBChecksumma SHA-512
1fa7799e8ad51b47a0da72669e756bebcda1b0ba93dae200f92206d3d0fe9c8d853bd99a0c35bea34f857c5e9e378ef910a83498dd47eee6cf67092efa6ef439
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Suhr, Ole B.

Sök vidare i DiVA

Av författaren/redaktören
Suhr, Ole B.
Av organisationen
Avdelningen för medicin
I samma tidskrift
Orphanet Journal of Rare Diseases
Neurologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 155 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 182 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf